Clinical Study

Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana

Figure 1

Kaplan-Meier survival curves of CD4+ T-lymphocyte recovery versus significant predictor variables of recovery for the 233 HIV-infected children on highly active antiretroviral therapy (HAART) from 2004 to 2009. (a) Age category: the median recovery time for ages <12 months, 1 to 6 years, and ≥6 years was 66, 52, and 69 weeks, respectively (logrank, 𝑃 = . 0 0 4 ). (b) Gender: the median recovery time for female and male was 58 and 67 weeks, respectively (logrank, 𝑃 = . 0 5 6 ). (c) WHO immune classification: the median recovery time for no evidence of suppression, evidence of moderate suppression, and evidence of severe suppression was 52, 38, and 77 weeks, respectively (logrank, 𝑃 = . 0 0 4 ). (d) Parental living status: the median recovery time for at least one parent alive and both parents dead or “unknown” was 59 and 75 weeks, respectively (logrank, 𝑃 = . 0 1 4 ).
896040.fig.001a
(a)
896040.fig.001b
(b)
896040.fig.001c
(c)
896040.fig.001d
(d)